Drawing based on the description in the official product monograph. No photo yet.
“16 mg / 12.5 mg: Each oblong, biconvex, peach-coloured tablet, with a score line on both sides and embossed on one side with "CH" on the left and "16" on the right side of the score line, contains candesartan cilexetil/hydrochlorothiazide 16 mg / 12.5 mg and the following non-medicinal ingredients: Croscarmellose Sodium, Hydroxypropyl Cellulose, Iron Oxide Red, Iron Oxide Yellow, Lactose Monohydra”
CH 16 pill
Pill with imprint CH 16 is orange, capsule and has been identified as Candesartan Cilexetil and Hydrochlorothiazide 16.0 mg / 12.5 mg. It is used for high blood pressure. It is supplied by Pharmascience Inc.
Sold in Canada
Candesartan Cilexetil and Hydrochlorothiazide 16.0 mg / 12.5 mg
- Brand
- PMS-Candesartan-HCTZ
- Imprint
- CH 16
- Strength
- Candesartan Cilexetil 16.0 mg / Hydrochlorothiazide 12.5 mg
- Used for
- High blood pressure
- Color
- Orange
- Shape
- Capsule / oblong
- Score
- Breaks into 2 pieces
- Form
- Tablet
- Manufacturer
- Pharmascience Inc
- Drug class
- ARB (blood pressure medicine)
- Sold in
- Canada
- DIN
- 02391295
Source: Health Canada's Drug Product Database and the official product monograph. Last checked .
Report a mistake
All Candesartan Cilexetil and Hydrochlorothiazide pills and guides
What is Candesartan Cilexetil and Hydrochlorothiazide used for?
Candesartan Cilexetil and Hydrochlorothiazide is used for high blood pressure.
- Medicine type
- ARB (blood pressure medicine); thiazide diuretic (water pill)
Official uses from the US prescribing label
Candesartan cilexitil and hydrochlorothiazide tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. There are no controlled trials demonstrating risk reduction with candesartan cilexitil and hydrochlorothiazide tablets. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than one drug to achieve blood pressure goals. For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program’s Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC). Numerous antihypertensive drugs, from a variety of pharmacologic classes and with different mechanisms of action, have been shown in randomized controlled trials to reduce cardiovascular morbidity and mortality, and it can be concluded that it is blood pressure reduction, and not some other pharmacologic property of the drugs, that is largely responsible for those benefits. The largest and most consistent cardiovascular outcome benefit has been a reduction in the risk of stroke, but reductions in myocardial infarction and cardiovascular mortality also have been seen regularly. Elevated systolic or diastolic pressure causes increased cardiovascular risk, and the absolute risk increase per mmHg is greater at higher blood pressures, so that even modest reductions of severe hypertension can provide substantial benefit. Relative risk reduction from blood pressure reduction is similar across populations with varying absolute risk, so the absolute benefit is greater in patients who are at higher risk independent of their hypertension (for example, patients with diabetes or hyperlipidemia), and such patients would be expected to benefit from more aggressive treatment to a lower blood pressure goal. Some antihypertensive drugs have smaller blood pressure effects (as monotherapy) in black patients, and many antihypertensive drugs have additional approved indications and effects (e.g., on angina, heart failure, or diabetic kidney disease). These considerations may guide selection of therapy. This fixed dose combination is not indicated for initial therapy (see DOSAGE AND ADMINISTRATION).
From the FDA-approved label on DailyMed (published Apr 21, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- Your pill shows CH 16. The parts can be split between the two sides, so turn the pill over and check both.
- It is orange, capsule.
- Its score line and coating match the details on this page.
- It came from a pharmacy package that names the same drug.
Sold in Canada as PMS-Candesartan-HCTZ by Pharmascience Inc.
In Canada: prescription only.
Ingredients
Active: Candesartan Cilexetil, Hydrochlorothiazide
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
IPX203 350
Carbidopa and Levodopa 87.5 mg / 350 mg
Orange & white, capsule, 23 mm
Used for Parkinson's disease
-
G 369
Topiramate 100 mg
Gray & orange, capsule, 19 mm
Used for bipolar disorder and focal seizures
-
G 368
Topiramate 50 mg
Gray & orange, capsule, 16 mm
Used for bipolar disorder and focal seizures
-
SD TC 5 mg
Tacrolimus 5 mg
Orange, capsule, 21 mm
Used for eczema
-
SD TC 1 mg
Tacrolimus 1 mg
Orange & yellow, capsule, 14 mm
Used for eczema
-
SD TC 0 5 mg
Tacrolimus 0.5 mg
Orange & pink, capsule, 11 mm
Used for eczema
Other Candesartan Cilexetil and Hydrochlorothiazide pills
- ACS 162 Candesartan Cilexetil and Hydrochlorothiazide 16 mg / 12.5 mg Pink, oval, 10 mm Used for high blood pressure
- 588 P Candesartan Cilexetil and Hydrochlorothiazide 16 mg / 12.5 mg White, oval, 10 mm Used for high blood pressure
- 19 4 Candesartan Cilexetil and Hydrochlorothiazide 16 mg / 12.5 mg White, oval, 10 mm Used for high blood pressure
- ACS Candesartan Cilexetil and Hydrochlorothiazide 16 mg / 12.5 mg Pink, oval, 10 mm Used for high blood pressure
- M X C1 Candesartan Cilexetil and Hydrochlorothiazide 16 mg / 12.5 mg Orange, round, 7 mm Used for high blood pressure
- ML71 Candesartan Cilexetil and Hydrochlorothiazide 16 mg / 12.5 mg Pink, oval, 10 mm Used for high blood pressure
- CS Candesartan Cilexetil and Hydrochlorothiazide 16 mg / 12.5 mg Orange, oval Used for high blood pressure
- L3 02 Candesartan Cilexetil and Hydrochlorothiazide 16 mg / 12.5 mg Pink, oval Used for high blood pressure